Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2014
Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylationStephanie A Nguyen, Owen D M Stechishin, H Artee Luchman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Ki-67: a prognostic factor for low-grade glioma?Barbara J Fisher, Elitza Naumova, Christopher C Leighton, et al.
Journal of Neuro-Oncology|June 21, 2020
PARP inhibition suppresses the emergence of temozolomide resistance in a model systemAlice L Yuan, Mathieu Meode, Melanie Tan, et al.
Neuro-Oncology|April 17, 2007
Survey of treatment recommendations for anaplastic oligodendrogliomaLauren E Abrey, David N Louis, Nina Paleologos, et al.
Journal of Neuro-Oncology|April 10, 2008
Toxicity from chemoradiotherapy in older patients with glioblastoma multiformeAngelique E Sijben, John B McIntyre, Gloria B Roldán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Imaging correlates of molecular signatures in oligodendrogliomasJoseph F Megyesi, Edward Kachur, Donald H Lee, et al.
Science Advances|October 13, 2021
Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancerAna Nikolic, Divya Singhal, Katrina Ellestad, et al.
Pageof 9